HDAC9 and chronic obstructive pulmonary disease: The diminished anti-inflammatory effects of ICSs in COPD may be caused by decreased HDAC expression and enzyme activity, which has been observed in the alveolar macrophages of patients with COPD and is thought to be mediated by oxidative stress [28, 29].